7 Biosimilars in the US: the next frontier for big pharma
Menu
PTAB Blog
Biosimilars Blog
RF 360

In the News

Insightful. Precise. Skilled.

Biosimilars in the US: The Next Frontier for Big Pharma

Authored by Brian A. Tollefson and Seth E. Cockrum

August 1, 2017

Rothwell Figg attorneys Brian A. Tollefson and Seth E. Cockrum published an article in the August 2017 issue of Financier Worldwide Magazine titled "Biosimilars in the US: the next frontier for big pharma."

Read the entire article here: https://www.financierworldwide.com/biosimilars-in-the-us-the-next-frontier-for-big-pharma#.WY30L1WGPAV